Skip to main content Deutsch

HD & Co Research Group

By naming our research group "HD" & "Co" we want to express that renal replacement therapy by hemodialysis is particularly important to us.

The importance of nephrology as a specialty of internal medicine is closely related to the development of renal replacement therapy through hemodialysis (HD) in the late 1960s.

Current projects include:


  • Relationship between volume status determined by bioimpedance spectrometry and absolute blood volume and their therapeutic implications
  • Qualitative study of gender differences in the transition from chronic renal failure to renal replacement therapy.
  •  Closing the loop in hemodialysis: an approach to precision medicine


  • Posttransplant Diabetes Mellitus (PTDM)
  • Gender Differences in Kidney Transplantation in Austria Compared to the United States (USRDS)

Fluid balance

  • Fluid therapy in the intensive care unit
  • Volume status determined by bioimpedance spectrometry and its implications in the general ward


  • COVID-19 and RAS blockade: randomized controlled clinical trial of the efficacy and safety of ACE inhibitors and angiotensin II receptor blockers in SARS-CoV-2 infection (The COVID-19-RAS study = substudy B of the Austrian CoronaVirus Adaptive Clinical Trial [ACOVACT])
  • Mass spectrometric RAS analysis (RAS fingerprint) in SARS-CoV-2 infection